NASDAQ
Eastgate Biotech Corp. (ETBI) has a free cash flow growth of -915.45% as of Friday, May 29, 2026. This represents a 269.08% decrease compared to its 12-month average of -248.03%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.